Xingzhi Han

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A tumor-targeting gambogic acid-loaded nanovaccine reprograms the tumor microenvironment for enhanced cancer immunotherapy.

A tumor-targeting gambogic acid-loaded nanovaccine reprograms the tumor microenvironment for enhanced cancer immunotherapy.

Journal: Journal of materials chemistry. B

Published: March 02, 2026

Biomimetic M1 Macrophage Membrane-Camouflaged Nanoplatform Remodels Tumor Microenvironment for Enhanced Antitumor Immunity.

Biomimetic M1 Macrophage Membrane-Camouflaged Nanoplatform Remodels Tumor Microenvironment for Enhanced Antitumor Immunity.

Journal: International journal of nanomedicine

Published: February 19, 2026

Inhibiting SLAMF8 modulates tumor-associated macrophages and restores CD8+ T cell-mediated antitumor immunity in colorectal cancer.

Inhibiting SLAMF8 modulates tumor-associated macrophages and restores CD8+ T cell-mediated antitumor immunity in colorectal cancer.

Journal: Oncoimmunology

Published: November 10, 2025

CSF1 inhibits ferroptosis in colorectal cancer cells by autocrine activation of the JAK/STAT3 signaling pathway.

CSF1 inhibits ferroptosis in colorectal cancer cells by autocrine activation of the JAK/STAT3 signaling pathway.

Journal: Biochemical pharmacology

Published: November 04, 2025

Macrophage-associated SLAMF9 is a potential therapeutic target for glioma.

Macrophage-associated SLAMF9 is a potential therapeutic target for glioma.

Journal: Translational cancer research

Published: September 06, 2025

Evaluation of the anti-tumor effect of gambogic acid loaded macrophage membranes nanoparticles combined with radiotherapy and anti-PD-1mAb in the colorectal cancer with liver metastasis model.

Evaluation of the anti-tumor effect of gambogic acid loaded macrophage membranes nanoparticles combined with radiotherapy and anti-PD-1mAb in the colorectal cancer with liver metastasis model.

Journal: Biomaterials advances

Published: May 06, 2025

Application of radiotherapy-preexcited gambogic acid dual targeting nanoparticles in colorectal cancer.

Application of radiotherapy-preexcited gambogic acid dual targeting nanoparticles in colorectal cancer.

Journal: RSC advances

Published: April 23, 2025

A nomogram and random forest model for predicting liver metastasis in patients with early-onset colorectal cancer.

A nomogram and random forest model for predicting liver metastasis in patients with early-onset colorectal cancer.

Journal: Scientific reports

Published: April 06, 2025

Manganese-based nanoparticles plus gambogic acid targeted hypoxic tumor microenvironment by enhancing ROS generation and provided antitumor treatment and improved immunotherapy.

Manganese-based nanoparticles plus gambogic acid targeted hypoxic tumor microenvironment by enhancing ROS generation and provided antitumor treatment and improved immunotherapy.

Journal: RSC advances

Published: December 04, 2024

SLAMF8 regulates Fc receptor-mediated phagocytosis in mouse macrophage cells through PI3K-Akt signaling.

SLAMF8 regulates Fc receptor-mediated phagocytosis in mouse macrophage cells through PI3K-Akt signaling.

Journal: Immunology letters

Published: August 11, 2024

Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells.

Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells.

Journal: International journal of nanomedicine

Published: February 14, 2023

SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer.

SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer.

Journal: Translational oncology

Published: November 11, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026